Xu X, Cheng H
J Inflamm Res. 2025; 18():325-345.
PMID: 39802503
PMC: 11724622.
DOI: 10.2147/JIR.S500518.
Ghorbanpour M, Salarvand S, Salarvand S, Shahsavari F, Shirkhoda M, Shakib P
BMC Cancer. 2024; 24(1):1256.
PMID: 39390390
PMC: 11465511.
DOI: 10.1186/s12885-024-12997-x.
Gattani V, Pawar S, Gupta C, Bhola N, Sonpal P, Agrawal P
Cureus. 2024; 16(6):e62341.
PMID: 39006683
PMC: 11246768.
DOI: 10.7759/cureus.62341.
Izzetti R, Nisi M
Diagnostics (Basel). 2024; 14(7).
PMID: 38611648
PMC: 11012073.
DOI: 10.3390/diagnostics14070735.
Mesolella M, Allosso S, Petruzzi G, Evangelista A, Motta G, Motta G
Cancers (Basel). 2024; 16(4).
PMID: 38398159
PMC: 10886710.
DOI: 10.3390/cancers16040768.
Has the 8th American joint committee on cancer TNM staging improved prognostic performance in oral cancer? A systematic review.
Erazo-Puentes M, Sanchez-Torres A, Aguirre-Urizar J, Bara-Casaus J, Gay-Escoda C
Med Oral Patol Oral Cir Bucal. 2024; 29(2):e163-e171.
PMID: 38368527
PMC: 10945871.
DOI: 10.4317/medoral.25983.
Increased Plasmatic Levels of Exosomes Are Significantly Related to Relapse Rate in Patients with Oral Squamous Cell Carcinoma: A Cohort Study.
Rodriguez-Zorrilla S, Lorenzo-Pouso A, Fais S, Logozzi M, Mizzoni D, Di Raimo R
Cancers (Basel). 2023; 15(23).
PMID: 38067397
PMC: 10705147.
DOI: 10.3390/cancers15235693.
Pretreatment Tumor Volume and Tumor Sphericity as Prognostic Factors in Patients with Oral Cavity Squamous Cell Carcinoma: A Prospective Clinical Study in 95 Patients.
Lucchi E, Cercenelli L, Maiolo V, Bortolani B, Marcelli E, Tarsitano A
J Pers Med. 2023; 13(11).
PMID: 38003916
PMC: 10672547.
DOI: 10.3390/jpm13111601.
Depth of Invasion: Influence of the Latest TNM Classification on the Prognosis of Clinical Early Stages of Oral Tongue Squamous Cell Carcinoma and Its Association with Other Histological Risk Factors.
Navarro Cuellar I, Espias Alonso S, Alijo Serrano F, Herrera Herrera I, Zamorano Leon J, Del Castillo Pardo de Vera J
Cancers (Basel). 2023; 15(19).
PMID: 37835576
PMC: 10571553.
DOI: 10.3390/cancers15194882.
Preoperative Determination of Depth of Invasion in Oral Cavity Squamous Cell Carcinoma by Standard Cross-Sectional Imaging With Computed Tomography and Positron Emission Tomography/Computed Tomography.
Naha K, Biedermann G, Nada A, Cousins J, Layfield L, Schnabel J
Cureus. 2023; 15(6):e40794.
PMID: 37485126
PMC: 10362784.
DOI: 10.7759/cureus.40794.
Protein Expression in Oral Squamous Cell Carcinoma: A Potential Marker for Progression and Prognosis.
El Hanbuli H, Sarie M
Iran J Pathol. 2022; 17(4):469-479.
PMID: 36532636
PMC: 9745753.
DOI: 10.30699/IJP.2022.550727.2856.
Immunology of Oral Squamous Cell Carcinoma-A Comprehensive Insight with Recent Concepts.
Venkatesiah S, Augustine D, Mishra D, Gujjar N, Haragannavar V, Awan K
Life (Basel). 2022; 12(11).
PMID: 36362963
PMC: 9695443.
DOI: 10.3390/life12111807.
Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Koyuncu C, Nag R, Lu C, Corredor G, Viswanathan V, Sandulache V
Cancer. 2022; 128(21):3831-3842.
PMID: 36066461
PMC: 9782693.
DOI: 10.1002/cncr.34446.
Emerging Biosensors for Oral Cancer Detection and Diagnosis-A Review Unravelling Their Role in Past and Present Advancements in the Field of Early Diagnosis.
Umapathy V, Natarajan P, Swamikannu B, Moses J, Jones S, Chandran M
Biosensors (Basel). 2022; 12(7).
PMID: 35884301
PMC: 9312890.
DOI: 10.3390/bios12070498.
Circular RNA mitochondrial translation optimization 1 homologue (CircMTO1) induced by zinc finger protein 460 (ZNF460) promotes oral squamous cell carcinoma progression through the microRNA miR-320a / alpha thalassemia/mental retardation, X-linked....
Zou C, Li X, Lv X, Wu S, Song J, Tang Z
Bioengineered. 2021; 12(2):9585-9597.
PMID: 34738503
PMC: 8810001.
DOI: 10.1080/21655979.2021.1997699.
Malignancies and Biosensors: A Focus on Oral Cancer Detection through Salivary Biomarkers.
Goldoni R, Scolaro A, Boccalari E, Dolci C, Scarano A, Inchingolo F
Biosensors (Basel). 2021; 11(10).
PMID: 34677352
PMC: 8533918.
DOI: 10.3390/bios11100396.
The Ratio of Preoperative Serum Biomarkers Predicts Prognosis in Patients With Oral Squamous Cell Carcinoma.
Ding M, Song Y, Jing J, Tian M, Ding L, Li Q
Front Oncol. 2021; 11:719513.
PMID: 34552873
PMC: 8452155.
DOI: 10.3389/fonc.2021.719513.
Salvage surgery for patients with residual/persistent diseases after improper or insufficient treatment of oral squamous cell carcinoma: can we rectify these mistakes?.
He Y, Liu Z, Sheng S, Gao W, Tang X, Li X
BMC Cancer. 2021; 21(1):878.
PMID: 34332566
PMC: 8325844.
DOI: 10.1186/s12885-021-08600-2.
Noninvasive Imaging Methods to Improve the Diagnosis of Oral Carcinoma and Its Precursors: State of the Art and Proposal of a Three-Step Diagnostic Process.
Romano A, Di Stasio D, Petruzzi M, Fiori F, Lajolo C, Santarelli A
Cancers (Basel). 2021; 13(12).
PMID: 34201237
PMC: 8228647.
DOI: 10.3390/cancers13122864.
A Combined Prediction Model for Lymph Node Metastasis Based on a Molecular Panel and Clinicopathological Factors in Oral Squamous Cell Carcinoma.
Wang S, Li T, Liu H, Wei W, Yang Y, Wang C
Front Oncol. 2021; 11:660615.
PMID: 33968767
PMC: 8100439.
DOI: 10.3389/fonc.2021.660615.